NCT01191996View on ClinicalTrials.gov

Safety Study of an Immunomodulating Microparticle to Treat Progressive Multiple Sclerosis

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

August 31, 2010

Primary Completion Date

June 30, 2012

Study Completion Date

November 30, 2012

Conditions
Secondary Progressive Multiple SclerosisPrimary Progressive Multiple Sclerosis
Interventions
BIOLOGICAL

MIS416

MIS416 intravenously every week

Trial Locations (1)

8011

Primorus Clinical Trials, 40 Stewart Street, Christchurch

Sponsors

Collaborators (1)

Primorus Clinical Trials
All Listed Sponsors
collaborator

Primorus Clinical Trials

UNKNOWN

collaborator

National Multiple Sclerosis Society

OTHER

lead

Innate Immunotherapeutics

INDUSTRY